Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period

This article was originally published in The Gray Sheet

Executive Summary

Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee

You may also be interested in...



MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed

Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains

MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed

Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains

Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists

CMS' reliance on the precise wording of Guidant's original national coverage determination request for expanded ICD use suggests the need for companies to tailor their requests to avoid overly broad interpretations

Related Content

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel